Pharmaceutical Compliance Consulting
XFDA Pharma Advisors helps pharma and biotech teams manage compliance risks. We support quality systems, validation, inspections, and market entry plans. Our Pharmaceutical Compliance Consulting services cover your product lifecycle. We help pharmaceutical, biotech, and medical device manufacturers meet FDA, EMA, MHRA, and CDSCO requirements.
From early planning to inspection readiness, our team helps you find compliance gaps, improve regulatory processes, and stay compliant as your needs change.
Why Pharmaceutical Projects Fail: Common Compliance Gaps
Compliance problems often start with poor communication. Different teams may handle regulatory work, quality, and post-market tasks. They may not always work together. This can leave gaps in the process.
These gaps can delay a project. For example, late regulatory decisions can slow down approval. Missing validation records can cause problems during an inspection. Poor CAPA work can also cause the same issue to happen again. New rules can create more work too, especially when digital tools or software are involved.
A pharmaceutical compliance consultant can help you find these issues early. Our pharma compliance consulting helps your team fix gaps before they lead to delays, findings, or other compliance problems.
Our Services
FDA & Pharmaceutical Compliance Consulting Services
XFDA Pharma Advisors provides specialized FDA consulting and pharmaceutical compliance services to pharmaceutical, biopharmaceutical, API, OTC, sterile manufacturing, and CMO/CDMO organizations in the United States and globally.
Our team of former FDA professionals and senior pharmaceutical industry experts provides hands-on support for FDA inspection readiness, CGMP compliance, regulatory remediation, laboratory operations, data integrity, quality systems, and complex manufacturing compliance challenges.
Whether you are preparing for an FDA inspection, responding to regulatory observations, addressing significant compliance deficiencies, or strengthening your Pharmaceutical Quality System, we provide practical, risk-based solutions designed to achieve and maintain a state of control.
FDA Inspection Readiness & Mock FDA Inspections
Prepare your facility, systems, documentation, and personnel before FDA arrives.
XFDA Pharma Advisors conducts mock FDA inspections and FDA inspection readiness assessments for Pre-Approval Inspections (PAIs), surveillance inspections, and other FDA inspections.
Our support includes FDA six-system assessments, facility and laboratory walkthroughs, document readiness, front-room and back-room preparation, SME interview coaching, inspection simulations, and identification of potential CGMP deficiencies.
FDA 483 Response Consulting
Received a Form FDA 483? XFDA Pharma Advisors helps organizations evaluate FDA observations, determine root causes and systemic impact, develop appropriate CAPAs, and prepare comprehensive responses supported by credible remediation plans and
evidence.
Our support includes 483 response development, root cause analysis, retrospective review strategies, CAPA development, remediation planning, effectiveness verification, and FDA follow-up inspection readiness.
FDA Warning Letter Remediation
XFDA Pharma Advisors provides comprehensive FDA Warning Letter response and remediation support for organizations facing significant CGMP and regulatory compliance issues.
Our former FDA and industry experts assist with comprehensive gap assessments, root cause investigations, systemic impact evaluations, CAPA development, retrospective reviews, data integrity remediation, quality-system remediation, FDA meeting preparation, and reinspection readiness.
FDA Pre-Approval Inspection (PAI) Readiness
Our PAI readiness consultants help pharmaceutical manufacturers prepare their facilities, systems, data, documentation, and personnel for FDA Pre-Approval Inspections.
Assessments may include CMC-to-site verification, process validation, analytical method readiness, laboratory controls, stability programs, batch records, data integrity, equipment qualification, quality systems, and employee interview preparation.
Pharmaceutical Data Integrity Consulting
XFDA Pharma Advisors performs comprehensive pharmaceutical data integrity assessments and remediation across laboratory, manufacturing, quality, and computerized systems.
Our assessments cover ALCOA+ principles, audit trails, user access, electronic records, chromatography systems, standalone equipment, spreadsheets, backup and restoration, data governance, retrospective reviews, and data integrity investigations.
Pharmaceutical Laboratory Compliance
Our pharmaceutical laboratory compliance consultants assess QC chemistry and microbiology operations from both scientific and FDA CGMP perspectives.
Areas of focus include OOS/OOT investigations, laboratory incidents, chromatography systems, audit trails, analytical method validation and verification, system suitability, stability programs, reference standards, equipment qualification, analyst training, electronic records, and laboratory data integrity.
CGMP & Pharmaceutical Quality Systems
XFDA Pharma Advisors helps organizations assess, strengthen, and remediate their Pharmaceutical Quality Systems and CGMP compliance programs.
Our expertise includes Quality Unit oversight, deviations, investigations, CAPA, change control, complaints, APR/PQR, quality risk management, training, document control, batch record review, internal audits, quality metrics, and management oversight.
Sterile Manufacturing & Aseptic Processing
Our sterile GMP consultants support sterile drug manufacturers with aseptic processing, contamination control, environmental monitoring, media fills, personnel qualification, gowning, cleaning and disinfection, cleanroom controls, microbiology systems, utilities, pharmaceutical water systems, and sterility assurance.
We also support FDA inspection readiness and EU GMP Annex 1 / Contamination Control Strategy (CCS) assessments.
API Manufacturing & ICH Q7 Compliance
XFDA Pharma Advisors provides API GMP consulting, ICH Q7 assessments, and FDA inspection readiness support for active pharmaceutical ingredient manufacturers.
Our assessments cover starting materials, raw materials, manufacturing controls, laboratory operations, analytical methods, impurities, process validation, cleaning, crosscontamination, investigations, CAPA, data integrity, supplier qualification, and quality oversight.
CMO/CDMO Audits & Supplier Qualification
Effective outsourcing requires effective quality oversight.
XFDA Pharma Advisors conducts CMO/CDMO audits, pharmaceutical supplier qualification audits, and independent GMP assessments to help organizations evaluate and oversee contract manufacturers, laboratories, and critical suppliers.
Our support includes qualification and requalification audits, quality agreement reviews, investigation and CAPA assessments, laboratory oversight, quality-system assessments, and regulatory inspection readiness.
CMC & Regulatory Compliance Support
Our experts provide compliance-focused CMC consulting and regulatory documentation support, including Module 3 reviews, manufacturing process documentation, specifications, analytical procedures, method validation and verification, stability, process validation, and raw material controls.
A key focus is identifying potential gaps between regulatory commitments and actual manufacturing, laboratory, and quality-system practices before they become regulatory issues.
Pharmaceutical Validation & Qualification
XFDA Pharma Advisors provides independent pharmaceutical validation and qualification consulting covering process validation, cleaning validation, equipment qualification, IQ/OQ/PQ, computerized system validation, laboratory equipment, facilities, utilities, and Continued Process Verification.
We evaluate whether programs are scientifically justified, appropriately documented, and capable of demonstrating a continued state of control.
Independent Remediation & Quality Oversight
For organizations undergoing significant regulatory or CGMP remediation, XFDA Pharma Advisors provides independent remediation and quality oversight from initial assessment through effectiveness verification.
Support may include CAPA oversight, retrospective reviews, investigation assessments, batch and laboratory record reviews, quality-system remediation, periodic effectiveness assessments, management reporting, and FDA reinspection readiness.
FDA Inspection Training & Coaching
Prepare your people—not just your documents.
XFDA Pharma Advisors provides customized FDA inspection training and coaching for executives, Quality Unit personnel, manufacturing teams, laboratory personnel, SMEs, and inspection support teams.
Training includes FDA investigator interactions, SME interview preparation, inspection behavior, front-room and back-room operations, document request management, data integrity, OOS investigations, CAPA, laboratory compliance, and Good Documentation Practices.
Need FDA Compliance Support?
Whether you are preparing for an upcoming FDA inspection or PAI, responding to a Form FDA 483 or Warning Letter, addressing data integrity concerns, or managing a complex CGMP remediation, our team is ready to help.
Talk With a Former FDA Consultant
Schedule a confidential consultation with XFDA Pharma Advisors to discuss your FDA compliance and inspection-readiness needs.
How We Work With You
A Practical, Risk-Based Approach to FDA Compliance.
Every engagement begins with understanding your specific regulatory and compliance needs. Whether you are preparing for an FDA inspection, addressing Form FDA 483 observations or a Warning Letter, strengthening your quality systems, or preparing for a PreApproval Inspection (PAI), XFDA Pharma Advisors provides a structured, risk-based approach tailored to your operation.
Step 1: Initial Consultation
We begin with an introductory consultation to understand your facility, products, regulatory status, current challenges, and objectives. This discussion allows us to identify your immediate priorities and determine the appropriate scope of support.
Step 2: Assessment & Gap Analysis
Our experts evaluate the relevant systems, procedures, records, and regulatory documentation against applicable FDA requirements and industry expectations. Depending on the engagement, this may include a comprehensive CGMP assessment, mock FDA inspection, laboratory or data integrity assessment, quality-system review, inspection-readiness assessment, or targeted review of a specific compliance concern. The objective is not simply to identify gaps, but to determine their significance and prioritize the areas requiring attention.
Step 3: Compliance Strategy & Remediation Roadmap
Based on our findings, we develop a practical roadmap that defines priorities, recommended corrective actions, responsibilities, and next steps. For remediation projects, we help your team address root causes and develop sustainable CAPAs rather than relying on short-term corrections. For inspection-readiness engagements, we focus resources on the systems and activities most likely to receive regulatory scrutiny
Step 4: Implementation & Hands-On Support
Our consultants work directly with your team to implement the agreed strategy. Support may include procedure development and revision, CAPA remediation, investigation review, data integrity improvements, quality-system enhancements, inspection preparation, frontroom and back-room coaching, CMC documentation review, and preparation of regulatory responses. Our approach is collaborative and practical, with solutions designed to work within your actual operations—not just on paper.
Step 5: Verification & Inspection Readiness
Before the engagement is completed, we evaluate whether key corrective actions and improvements have been effectively implemented. When FDA inspection readiness is the objective, this may include follow-up assessments, mock interviews, document challenges, facility walkthroughs, inspection simulations, and verification of supporting evidence.
Step 6: Ongoing Regulatory & Compliance Support
FDA compliance does not end when an audit or remediation project is completed. XFDA Pharma Advisors can continue supporting your organization through FDA inspections, regulatory responses, CAPA effectiveness verification, quality-system improvements, CMO/CDMO oversight, and evolving compliance needs.
From identifying the problem to implementing and verifying the solution, XFDA Pharma Advisors provides experienced, hands-on support throughout the FDA compliance lifecycle.
Why Choose XFDA Pharma Advisors
XFDA Pharma Advisors blends regulatory expertise with practical assistance. We have expertise in quality, regulation, validation, audits, and market access. This enables us to see the whole picture rather than just one aspect.
Industries We Serve
Specialized FDA & CGMP Consulting Across Pharmaceutical and Life Sciences Manufacturing.
XFDA Pharma Advisors supports pharmaceutical, biopharmaceutical, and regulated product manufacturers with practical, inspection-focused compliance solutions. Our team of former FDA investigators, compliance professionals, and senior industry experts brings extensive experience in FDA inspections, CGMP compliance, quality systems, laboratory operations, data integrity, and regulatory remediation. Our experience includes:
Prescription Pharmaceuticals
Brand and generic drug manufacturers, including NDA and ANDA products.
Active Pharmaceutical Ingredients (APIs)
API and intermediate manufacturers operating under FDA CGMP and ICH Q7 expectations.
Sterile & Aseptic Products
Sterile drug products, aseptic processing operations, contamination control, and microbiological systems.
Biologics & Biopharmaceuticals
Quality systems, manufacturing controls, laboratory operations, and FDA inspection readiness.
Over-the-Counter (OTC) Drugs
OTC drug manufacturing, testing, packaging, quality systems, and FDA CGMP compliance.
Contract Manufacturers & CDMOs/CMOs
FDA inspection readiness, qualitysystem assessments, client oversight, supplier qualification, and remediation support.
Pharmaceutical Laboratories
QC chemistry and microbiology laboratories, data integrity, OOS/OOT investigations, method validation/verification, and laboratory controls.
Drug-Device Combination Products
CGMP and quality-system support for pharmaceutical operations involving combination products.
Transdermal & Drug-Delivery Products
Manufacturing, laboratory, cleaning, cross-contamination, and quality-system controls.
Cosmetics & Personal Care Products
FDA compliance and MoCRA readiness, including quality systems, manufacturing controls, and facility preparedness.
Whether preparing for an FDA Pre-Approval Inspection (PAI), surveillance inspection, responding to a Form FDA 483 or Warning Letter, addressing data-integrity concerns, or strengthening an existing Pharmaceutical Quality System, XFDA Pharma Advisors provides hands-on support based on real FDA and industry experience.
Discuss Your Pharmaceutical Compliance Challenge
Have a compliance question or a project that needs support? Get in touch with us for a free assessment. Our Pharmaceutical Compliance Consulting can help you find gaps, address key issues, and prepare for your next regulatory step.
Response Time: We respond to all inquiries within 24 hours on business days.
Frequently Asked Questions
This will vary based on the project. The gap assessment takes approximately four weeks, and if a full QMS project is undertaken, the process can take between six and twelve months. Many clients start with one project and add more support as needed.
We work with both. Our support can help startups establish the right systems from the beginning. Existing businesses might require assistance with remediation, inspections, or other compliance matters. Our pharma compliance consulting can be tailored to suit various requirements.
We work with pharmaceutical manufacturers, biotech companies, medical device companies, and CMOs. We also have experience with sterile products, oral solids, biologics and advanced therapies.
Yes. We meet the requirements of the CDSCO such as Schedule M, Plant licensing, product permissions, and Inspection readiness. We can assist you in understanding your requirements and preparing your systems and documents.
We include training and guidance as part of our work. Your team learns how to manage the processes, not just what needs to be changed. This contributes to pharmaceutical regulatory compliance in the long term.